![]() |
Volumn 30, Issue 1, 2011, Pages
|
The function and mechanism of COX-2 in angiogenesis of gastric cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA1 INTERFERON;
ANGIOPOIETIN 1;
ANGIOPOIETIN 2;
ANGIOPOIETIN RECEPTOR;
CD31 ANTIGEN;
CYCLOOXYGENASE 2;
FIBROBLAST GROWTH FACTOR 4;
GELATINASE A;
OSTEONECTIN;
OSTEOPROTEGERIN;
PF4 PROTEIN;
PLATELET DERIVED GROWTH FACTOR BB;
PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;
PRL PROTEIN;
PROTEIN;
PTN PROTEIN;
SERINE PROTEINASE INHIBITOR;
SERPINF1 PROTEIN;
SMALL INTERFERING RNA;
THBS 2 PROTEIN;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;
TRANSFORMING GROWTH FACTOR BETA2;
UNCLASSIFIED DRUG;
VASCULAR ENDOTHELIAL GROWTH INHIBITOR;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR 1;
VASCULOTROPIN RECEPTOR 2;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER CELL;
CARCINOGENESIS;
CARCINOGENICITY;
CELL GROWTH;
CELL MIGRATION;
CELL PROLIFERATION;
CONTROLLED STUDY;
DOWN REGULATION;
FEMALE;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MICROARRAY ANALYSIS;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
STOMACH CANCER;
UMBILICAL VEIN ENDOTHELIAL CELL;
WESTERN BLOTTING;
ANIMAL;
CANCER TRANSPLANTATION;
CELL CULTURE;
CELL MOTION;
CYTOLOGY;
DRUG EFFECT;
ENDOTHELIUM CELL;
EXPERIMENTAL NEOPLASM;
GENE EXPRESSION PROFILING;
GENETICS;
NEOVASCULARIZATION (PATHOLOGY);
NUDE MOUSE;
PHYSIOLOGY;
RNA INTERFERENCE;
STOMACH TUMOR;
TUMOR CELL LINE;
UMBILICAL VEIN;
VASCULARIZATION;
ANIMALS;
CELL LINE, TUMOR;
CELL MOVEMENT;
CELL PROLIFERATION;
CELLS, CULTURED;
CYCLOOXYGENASE 2;
ENDOTHELIAL CELLS;
FEMALE;
GENE EXPRESSION PROFILING;
HUMANS;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
NEOVASCULARIZATION, PATHOLOGIC;
RNA INTERFERENCE;
RNA, SMALL INTERFERING;
STOMACH NEOPLASMS;
UMBILICAL VEINS;
|
EID: 78951469547
PISSN: None
EISSN: 17569966
Source Type: Journal
DOI: 10.1186/1756-9966-30-13 Document Type: Article |
Times cited : (36)
|
References (13)
|